Cargando…
NLRP3 inflammasome inhibition of OP9 cells enhance therapy for inflammatory bowel disease
Mesenchymal stem cells (MSCs) are becoming more popular in therapy. Therefore, in-depth studies on mesenchymal stem cells in therapy are urgently needed. However, the difficulty in culturing and propagating MSCs in vitro complicates potential studies on MSCs in a murine model. OP9 cells are a stroma...
Autores principales: | Chen, Yutong, Meng, Weicheng, Ren, Guangming, An, Ning, Zhang, Jing, Liu, Zhixin, Wu, Xiaoshuang, Yin, Wen, Hu, Xingbin, Liu, Zheng, Feng, Fan, Chen, Yaozhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362138/ https://www.ncbi.nlm.nih.gov/pubmed/37483815 http://dx.doi.org/10.1016/j.heliyon.2023.e18038 |
Ejemplares similares
-
Platelet-Derived Mitochondria Attenuate 5-FU-Induced Injury to Bone-Associated Mesenchymal Stem Cells
por: Chen, Yutong, et al.
Publicado: (2023) -
NLRP3 inflammasome of renal tubular epithelial cells induces kidney injury in acute hemolytic transfusion reactions
por: Liu, Zhixin, et al.
Publicado: (2021) -
Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes
por: Chen, Yaozhen, et al.
Publicado: (2018) -
NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019) -
Role of NLRP3 inflammasome in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2019)